Peripheral arterial disease: Diagnosis and management in general practice

Australian Family Physician

Volumn 42, Issue 6, 2013, Pages 397-400

  Au, Thuy Bich ^a,b   Golledge, Jonathan ^c   Walker, Philip J ^d   Haigh, Kate ^e   Nelson, Mark ^f  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

^c JAMES COOK UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e TOOWOOMBA HOSPITAL   (Australia)

^f UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Health behaviour; Peripheral arterial disease; Risk factors; Risk reduction behaviour

Indexed keywords

CARDIOVASCULAR AGENT;

ANAMNESIS; ANKLE BRACHIAL INDEX; ARTICLE; AUSTRALIA; COMPUTER ASSISTED TOMOGRAPHY; DIET THERAPY; GENERAL PRACTICE; HUMAN; KINESIOTHERAPY; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIMODALITY CANCER THERAPY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL EXAMINATION; RISK FACTOR; VASCULAR SURGERY;

ANKLE BRACHIAL INDEX; AUSTRALIA; CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; DIET THERAPY; EXERCISE THERAPY; GENERAL PRACTICE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL HISTORY TAKING; PERIPHERAL ARTERIAL DISEASE; PHYSICAL EXAMINATION; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR SURGICAL PROCEDURES;

EID: 84880742918     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33(Suppl 1).
2. Fowkes FGR, Houseley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.
3. Ramos R, Quesada M, Solanas P, et al. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the anklebrachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg 2009;38:305-11.
4. Australian Institute of Health and Welfare. Cardiovascular disease: Australian facts 2011. Cardiovascular disease series. Cat. no. CVD 53. Chapter 8: Peripheral vascular disease, pp. 117-124. Available at www.aihw.gov.au/publication-detail/?id=10737418510 [Accessed 21 March 2013.
5. McDermott MM. The magnitude of the problem of peripheral arterial disease: epidemiology and clinical significance. Cleve Clin J Med 2006;73(Suppl 4):S2-7.
6. McDermott M, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensivelytreated in patients with PAD than in patients with coronary artery disease. J Gen Intern Med 1997;12:209-15.
7. Criqui M, Langer R, Fronek A, et al., Mortality over a period of 10 years in patients with peripheral artery disease. N Engl J Med 1992;326:326-81.
8. Aung PP, Maxwell HG, Jepson RG, Price JF, Leng GC. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev 2007;4:CD000123.
9. Ferket B, Spronk S, Colkesen E, Hunink M. Systematic review of guidelines on peripheral artery disease screening. Am J Med 2012;125:198-208.
10. Rooke T, Hirsch A, Misra S, et al. 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011;58:2020-45.
11. Cleveland Clinic. Peripheral arterial disease (PAD) and exercise. 2012. Available at http://my.clevelandclinic.org/heart/disorders/vascular/padexercise.aspx [Accessed 18 July 2012].
12. Norgren L, Hiatt WR, Dormandy JA, et al. Inter- Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33(Suppl 1):S1-75.
13. Barba A, Estallo L, Rodríguez L, Baquer M, Céniga M.V.d. Detection of abdominal aortic aneurysm in patients with peripheral artery disease. Eur J Vasc Endovasc Surg 2005;30:504-8.
14. Al-Qaisi M, Nott DM, King DH, Kaddoura S, Hamady M. Imaging of peripheral vascular disease. Medical Imaging 2009;2:25-34.
15. Mukherjee D, Yadav JS. Update on peripheral vascular diseases: from smoking cessation to stenting. Cleveland Clinic J Med 2001;68:723-33.
16. Conen D, Everett BM, Kurth T, et al. Smoking, smoking status, and risk for symptomatic peripheral artery disease in women: a cohort study. Ann Intern Med 2011;154:719-26.
17. Faulkner K, House A, Castleden W. The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease. Med J Aust 1983;1:217-9.
18. Mills E, Eyawo O, Lockhart I, Kelly S, Wu P, Ebbert J. Smoking cessation reduces postoperative complications: a systematic review and metaanalysis. Am J Med 2011;124:144-54.
19. Gardner A, Poehlman E. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995;274:975-80.
20. Watson L, Ellis B, Leng G. Exercise for intermittent claudication. Cochrane Database Syst Rev 2008;4:CD000990.
21. McDermott M, Ades P, Guralnik J, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009;301:165-C74.
22. Miller TD, Balady GJ, Fletcher GF. Exercise and its role in the prevention and rehabilitation of cardiovascular disease. Ann Behav Med 1997;19:220-9.
23. Ahimastos A, Pappas E, Buttner P, Walker P, Kingwell B, Golledge J. A meta-analysis of theoutcome of endovascular and noninvasive therapies in the treatment of intermittent claudication. J Vasc Surg 2011;54:1511-21.
24. National Health and Medical Research Council. Dietary guidelines for Australian adults. 2003. Available at www.nhmrc.gov.au/_files_nhmrc/publications/attachments/n33.pdf [Accessed 17 May 2013].
25. Robless P, Mikhailidis D, Stansby G. Antiplatelet agents for intermittent claudication. Cochrane Database Syst Rev 2009;(1).
26. Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease - a meta-analysis of randomized trials. JAMA 2009;301:1909-19.
27. Fowkes FG, Price JF, Stewart MC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 2010;303:841-8.
28. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
29. Heart Protection Study Collaborative Group. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo controlled trial. Lancet 2002;360:7-22.
30. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998;339:1349-57.
31. Schainfeld RM. Management of peripheral arterial disease and intermittent claudication. J Am Board Fam Pract 2001;14:443-50.
32. Mohler ER. Medical management of claudication. In: UpToDate. Basow DS, editor. UpToDate, Waltham, MA, 2012 [Accessed 27 March 2013].
33. Ahimastos AA, Lawler A, Reid CM, Blombery PA, Kingwell BA. Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann Intern Med 2006;144:660-4.
34. Ahimastos A, Walker P, Askew C, et al. Ramipril therapy in patients with intermittent claudication: a randomised, double-blind, placebo-controlled trial. JAMA 2013;309:453-60.
35. Paravastu S, Mendonca D, Silva AD. Beta blockers for peripheral arterial disease. Cochrane Database Syst Rev 2010;(3).
36. Li X, Li J, Nguyen T, et al. Effect of statins and calcium channel blockers on all-cause mortality and cardiovascular and cerebrovascular disease mortality in 958 Chinese hospitalised patients with peripheral arterial disease after 13 months of follow-up. J Health Science 2007;53:226-33.
37. Lane DA, Lip GY. Treatment of hypertension in peripheral arterial disease. Cochrane Database Syst Rev 2009;4:CD003075.
38. Scottish Intercollegiate Guidelines Network. Diagnosis and management of peripheral arterial disease: a national clinical guideline. 2006. Available at www.sign.ac.uk/pdf/sign89.pdf [Accessed 3 July 2012].
39. Kleijnen J, Mackerras D. Vitamin E for intermittent claudication. Cochrane Database Syst Rev 2009;(1).
40. Jepson RG, Kleijnen J, Leng G. Garlic for peripheral arterial occlusive disease. Cochrane Database Syst Rev 2008;(3).
41. Nicolaï SP, Kruidenier LM, Bendermacher BL, Prins MH, Teijink JA. Ginkgo biloba for intermittent claudication. Cochrane Database Syst Rev 2009;2:CD:006888.